1.
Ates M, Karup S, Ugurlu S. Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency. Reumatismo [Internet]. 2023 Dec. 19 [cited 2024 Nov. 25];75(4). Available from: https://www.reumatismo.org/reuma/article/view/1543